Profile photo Nadia Haj Mohammad

Nadia Haj Mohammad

Assistant Professor - medical

Strategic program(s):

Biography

Dr. N. Haj Mohammad (1976) has been working as a medical oncologist in the UMC Utrecht since 2014. She studied pharmacy in the same city, and completed her pharmacy training in 2001. One year earlier, she started Medical school at the University of Amsterdam. She combined her training as a medical-oncologist at the AMC with PhD research in the clinical outcomes of treatments for gastroesophageal and pancreatic carcinoma.

She is member of the national guidelines for hepatocellular carcinoma and bile duct carcinoma. She is a board member of the Dutch Upper GI Cancer group.

Her research focuses on clinical outcomes of gastroesophageal and primary liver cancers. She is national PI of the phase 2 LyRICX study in metastatic gastroesophageal cancer and is local PI of multiple investigator and sponsor investigated studies within tumors of the upper digestive tract and primary liver tumors.

Strategic program(s):

Contact

Research groups

Primary Liver Tumors research group

Research aim

To improve surveillance, diagnostics, treatment, and outcome for patients with primary liver tumors (hepatocellular carcinoma and cholangiocarcinoma) by interdisciplinary and (inter-)national collaborative research

Go to group

Recent publications

Socioeconomic disparities in treatment and survival of oesophageal and gastric cancer in the Netherlands Dillen C van der Aa, Mats D Teeken, Hanneke W M van Laarhoven, Suzanne S Gisbertz, Sjoerd M Lagarde, Nadia Haj Mohammad, Peter S N van Rossum, Rob H A Verhoeven, Mark I van Berge Henegouwen
The Lancet Regional Health - Europe, 2026, vol. 65
Association between effectiveness of treatment with curative intent and outcomes of first-line systemic therapy in metachronous metastatic gastroesophageal adenocarcinoma D Kamp, A M May, M J M van Velzen, S Mook, J E Freund, B Mostert, R H A Verhoeven, H W M van Laarhoven, N Haj Mohammad
British Journal of Cancer, 2026, vol. 134, p.1420-1428
Effects of exercise and diet in patients with incurable gastroesophageal cancer Aniek Bonhof, Anouk E Hiensch, Nicolette J Wierdsma, Linde F Huis In 't Veld, Sandra D Bakker, Aart Beeker, Marjan Davidis-van Schoonhoven, Helga Droogendijk, Jan C Drooger, Joeri A J Douma, Ruben S A Goedegebuure, Nadia Haj Mohammad, Irene E G van Hellemond, Karin Herbschleb, Johan J B Janssen, Bianca Mostert, Marije Slingerland, Dirkje Sommeijer, Liesbeth Timmermans, Arjan J Verschoor, Vincent A de Weger, Harm Westdorp, Miriam L Wumkes, Anne M May, Hanneke W M van Laarhoven
JNCI cancer spectrum, 2026, vol. 10
Patient-derived cancer organoids to tailor personalized treatment strategies in upper gastrointestinal malignancies Ingrid A Franken, Georg Busslinger, Bas L A M Weusten, Lodewijk A A Brosens, Jelle P Ruurda, Nadia Haj Mohammad, Stella Mook, Hans Clevers, Richard Van Hillegersberg
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2026, vol. 39
Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma-PUMP-2 Trial Stijn Franssen, Merve Rousian, Wills F Filipe, Florian E Buisman, Britte H E A Ten Haaft, Rutger-Jan Swijnenburg, Bianca Mostert, Nadia Haj Mohammad, Jeroen Hagendoorn, Michael Doukas, Heinz-Josef Klümpen, Marjolein Y V Homs, Bas Groot Koerkamp
Journal of Clinical Oncology, 2025, vol. 44
Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer Rob H A Verhoeven, Steven C Kuijper, Marije Slingerland, Bas Wijnhoven, Mark I van Berge Henegouwen, Peter S N van Rossum, Sarah Derks, Bianca Mostert, Nadia Haj Mohammad, Hanneke W M van Laarhoven
International Journal of Cancer, 2025, vol. 158, p.1292-1301